ArticleCancer immunology, immunotherapy : CII2025
LAG3 as a marker of immune activation in esophageal squamous carcinoma treated with concurrent chemoradiotherapy.
Yuxuan Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it